Objective: This study aims to investigate the relationship between serum lipids and bone mineral density in ankylosing spondylitis patients. Methods: A total of 94 ankylosing spondylitis patients fulfilling the 1984 Modified New York Criteria who had serum lipid levels and bone mineral density scores in medical records were included in this study. These patients treated with nonsteroid antiinflammatory drugs. Their files were examined in detail. Later demographic and laboratory features were recorded to the research form. Dual-energy X-ray absorptiometry was used to assess bone mineral density in two bone sites of femur (neck, intertrochanteric zone and trochanter) and spinal lumbar vertebras (Lumbar 1-Lumbar 4). Results: Significant and positive correlation was found between high density lipoprotein and femoral neck bone mineral density (r = 0.356, p = 0.021) in osteopenic group and in osteoporotic group (r = 0.005, p = 0.040). Conclusion: According to our study significant and positive correlations are found between high density lipoprotein and femoral neck bone mineral density in osteopenic and osteoporotic group. However, we believe that more studies are needed about this research.
The European Research Journal 2019;5(2):355-360 nkylosing spondylitis (AS) is an inflammatory rheumatic disorder and a prototype of spondyloarthritis, characterized by axial skeleton and sacroiliac joint involvement. In 90% of patients, the first symptoms develop before 40-45 years and the mean average age is 28.3 years [1] .
The incidence of osteopenia or osteoporosis in these patients is reported to be 19-62% [2] . Bone loss in AS appears to be multifactorial and involves different mechanisms at different stages of disease [3] .
Also there is association between inflammation and lipid changes [4] . The association between serum lipids and bone mineral density (BMD) has been investigated in previous studies [5] [6] [7] but these relationships have not yet been described in AS.
In our study, we investigated the relationship between serum lipids and BMD in AS patients. To the authors' knowledge, this is the first study in AS patients which evaluated the relationships between serum lipids and BMD.
METHODS
Our study was carried out at Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Aydın, Turkey from January 2017 to June 2017. The ethics committee of the Institution approved the study and all patients signed the Informed consent form. 94 male patients who were diagnosed with AS according to the 1984 Modified New York criteria and who had serum lipid levels and BMD scores in medical records were included in this study. The all medical records of these patients in our hospital were analysed and later ages, gender, body weight and height, body mass index (BMI), serum lipid levels [high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), total cholesterol (TC) and total triglyceride (TG) and BMD scores of the patients were recorded to the research form. AS patients (94 male) were treated with nonsteroid antiinflammatory drugs (NSAIDs ).
Dual-energy X-ray absorptiometry (DXA) was used to assess BMD in two bone sites of femur (neck, intertrochanteric zone and trochanter) and spinal lumbar vertebras (Lumbar 1-Lumbar 4). Calibration of bone densitometer (Hologic, Inc., Waltham, MA, USA) was performed weekly by using appropriate phantoms. The precision rror (PE) is usually expressed as the coefficient of variation (CV), which is the ratio of the standard deviation to the mean of the measurements [8] . The PE for BMD measurements was 2 to 3% in the femoral and 1 to 1.5% in the lumbar regions. All scans were performed according to the manufacturer's guidelines. In patients with spinal implant the involved lumbar vertebras were excluded and the mean BMD of noninvolved vertebras was entered into the analysis.
Baseline characteristics and differences of basic features among male subjects with AS were presented in Table 1 .
HDL cholesterol (HDLc), LDL cholesterol (LDLc), TC and TG were measured by spectrophotometric enzymatic colorimetric tests using Abbott Diagnostics and VLDL cholesterol (VLDLc) by using the formula VLDLc = Triglycerides /5. Normal ranges were considered to be: 35-55 mg/dL for HDLc, 30-130 mg/dL for LDLc, 0-200 mg/dL for TC and 0-149 mg/dL for TG. Body mass index (BMI) was calculated by the formula BMI = weight/height2, where height is expressed in meters and weight in kilograms. We considered patients with a T-score etween -1.0 and -2.49 to be osteopenic and those with a T-score < -2.5 to have osteoporosis.
Inclusion criteria were male AS subjects. Because of some conditions which could potentially affect serum lipid levels, the patients who had some disorders of neurologic, endocrinologic and cardiovascular systems, and a history of using some drugs (e.g., oral contraceptives, corticosteroids, lipid lowering drugs, hormones, thyroid hormones, anticonvulsive drugs, heparin, aluminum containing antacids, lithium, omega-3 fatty acids, or other nutrients supplements) and smoking or alcohol consumption were excluded from the study.
Statistical Analysis
Normally distributed variables were tested by Ttest in AS patients. To compare the correlations between serum lipids and BMD. Spearman correlation test was used. Partial correlation with adjustment for weight, height, BMI and age was used to determine the association between BMD in different bone sites and serum lipids. Statistical analyses were carried out using the Statistical Package for the Social Sciences (SPSS), ver 19.0 (IBM Corp.; Armonk, NY, USA) and p < 0.05 was considered to be statistically significant. 
RESULTS

Ninety
DISCUSSION
The association between serum lipids and BMD has been investigated in previous studies [5] [6] [7] . Hadis et al. [5] investigated the relationships between serum lipids and BMD in 85 male patients with spinal cord injury (SCI). As a result of this study a positive correlation between HDL and femoral neck BMD (r = 0.33, p = 0.004) was found although any a relation between others and BMD scores had no. Their study does not support a strong association between serum lipids and BMD in patients with SCI. Garg et al. [6] studied the relationships of lipid parameters with BMD in 2,347 participants. In this investigation, a total of 924 male,788 premenopausal and 635 postmenopausal female participants were included. As a result of this study, BMD of male participants at femoral neck, femur total and lumbar spine were negatively correlated with TC and LDLc and positively with TG. In premenopausal women, there was no correlation of any lipid parameters with BMD. In postmenopausal women, a significant negative correlation was found between femur total BMD with TC and LDLc. Furthermore, there was a negative correlation between TG and femur BMD, while a positive correlation was found between HDLc and the same region in these women. They reported a weak correlation between lipid parameters and BMD at various sites in men, pre-and post-menopausal women. Catalina et al. [7] investigated lipid profile in 610 postmenopausal women with osteoporosis. Authors were grouped according to the age (< 50 years, 51-60 years, 61-70 years and >0 years) and presence or absence of a history of fragility fracture of patients. In this research, they determined significant correlations between BMD with BMI and lipid profile. The results presented in this report provide support for an association between osteoporosis and the circulating lipid profiles. Makovey et al. [9] investigated the association between TC and BMD in 497 female patients (224 premenopausal and 273 postmenopausal women). They showed that BMD is significantly negatively correlated with TC and LDLc in postmenopausal [11] study included 340 postmenopausal women between 50-75 years. They showed that serum TC is significant negative correlated with BMD at the lumbar spine (r = -0.21, p < 0.0001) and distal forearm (r =-0.14, p = 0.013), but not at the hip. They suggested that the weak associations between spine BMD and TC can be explained by the fact that both variables are simultaneously affected by estrogen deficiency rather than by a direct influence of serum cholesterol on osteoblast function. Uyama et al. [12] investigated the relation of carotid atherosclerosis to BMD in 30 postmenopausal women aged 67 to 85 years. They demonstrated a significant correlation of plaque score with TC level and low total BMD. In the prospective study of Samelson et al. [13] assesed the association between TC and BMD in 712 female and 450 male patients. No significant association between TC and BMD was found in female and male patients for any of the bone sites considered. The responsible mechanisms about the association between osteoporosis and the lipid profile was announced in some studies [16, 17] . Franceschi et al. [16] explained this association as a molecular level "inflammaging" theory which can lead to osteoporosis. In another theory, osteoporosis is based on the "osteo-lipo-vascular interactions". Mesenchymal stem cells are capable of differentiating into osteoblasts, vascular smooth muscle cells and adipocytes. As a result of this study bone, adipose and vascular systems provide the epidemiological link between hyperlipidemia and osteoporosis [17] .
CONCLUSION
As a result of our study we aimed to investigate the relationship between serum lipids and BMD in AS patients. We enrolled a total of 94 AS patients fulfilling the 1984 Modified New York Criteria who had serum lipid levels and BMD scores. We found significant and positive correlations between between HDL and femoral neck BMD in osteopenic and osteoporotic group. Our study supported the association between osteoporosis and the lipid profile. We can suggest that lipid reducing medications such as statins increases BMD and statins can be used in OP treatment.
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